This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ram, Z. Articles by Hadani, M. Search for Related Content PubMed PubMed Citation Articles by Ram, Z. Articles by Hadani, M.

Stroke, Vol 22, 922-927, Copyright © 1991 by American Heart Association

ARTICLES

Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats

Z Ram, M Sadeh, I Shacked, A Sahar and M Hadani
Department of Neurosurgery, Chaim Sheba Medical Center, Sackler School of Medicine, Tel-Hashomer, Israel.

We induced experimental delayed cerebral vasospasm by the intracisternal injection of greater than 0.5 ml blood in 30 rats. Seventy-two hours later the basilar artery was exposed via the transclival approach and photographed at high-power magnification through an operating microscope. We then evaluated the effect of topical (n = 30) and intravenous (n = 20) magnesium sulfate on the spastic artery by computerized image analysis. A greater than 50% reduction in baseline diameter of the basilar artery was observed in the rats subjected to subarachnoid hemorrhage compared with the 10 controls (p less than 0.0001). Intravenous magnesium sulfate dilated the spastic artery to approximately 75% of the baseline diameter in control rats (p less than 0.0001). Topical magnesium sulfate caused dramatic dilation of the basilar artery in both the control and the subarachnoid hemorrhage groups to near 150% of the baseline diameter in the controls (p less than 0.001). All rats receiving intravenous magnesium sulfate reached therapeutic plasma levels of the ion. Hemodynamic effects were mild and immediately reversible upon cessation of magnesium sulfate administration. We suggest that magnesium has a role in the treatment of subarachnoid hemorrhage-induced vasospasm in humans.

This article has been cited by other articles:

				W.S. Bartynski Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1043 - 1049. [Abstract] [Full Text] [PDF]

				D. Zemke, M. U Farooq, A. Mohammed Yahia, and A. Majid Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy? Vascular Medicine, August 1, 2007; 12(3): 243 - 249. [Abstract] [PDF]

				D. H. Rhoney and D. Parker Jr Considerations in Fluids and Electrolytes After Traumatic Brain Injury Nutr Clin Pract, October 1, 2006; 21(5): 462 - 478. [Abstract] [Full Text] [PDF]

				W. M. van den Bergh and on behalf of the MASH Study Group Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage: A Randomized Controlled Trial Stroke, May 1, 2005; 36(5): 1011 - 1015. [Abstract] [Full Text] [PDF]

				K. W. Muir and K. R. Lees Dose Optimization of Intravenous Magnesium Sulfate After Acute Stroke Stroke, May 1, 1998; 29(5): 918 - 923. [Abstract] [Full Text] [PDF]

				C.-Y. Yang Calcium and Magnesium in Drinking Water and Risk of Death From Cerebrovascular Disease Stroke, February 1, 1998; 29(2): 411 - 414. [Abstract] [Full Text] [PDF]

				K. W. Muir and K. R. Lees A Randomized, Double-Blind, Placebo-Controlled Pilot Trial of Intravenous Magnesium Sulfate in Acute Stroke Stroke, July 1, 1995; 26(7): 1183 - 1188. [Abstract] [Full Text]